Passage Bio Inc (PASG) Annual Balance Sheets

Annual · GAAP · USD millions
Access PASG quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Passage Bio Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent46.30
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments46.00
Other Current Assets0.83
Prepaid Expense And Other Assets Current0.63
Total Current Assets47.76
Equipment/Property/Plant Net4.11
Other Assets, Noncurrent10.41
Prepaid Research And Development Asset Current0.83
Operating Lease Right Of Use Asset10.17
Total Assets62.28
Liabilities
Accounts Payable, Current AC1.11
Other Liabilities, Current21.97
Total Current Liabilities23.08
Total Long-term Debt0.00
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent20.44
Accrued Expenses And Other Current Liabilities4.65
Operating Lease Liability Noncurrent20.44
Total Liabilities43.53
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock723.51
Retained Earnings / Accumulated Deficit-704.76
Other Equity0.00
Common Stockholder's Equity18.76
Total Stockholder's Equity18.76
Liabilities & Stockholder's Equity62.28
4 historic quarters locked

Sign in to unlock the full Passage Bio Inc balance sheet history.

About Passage Bio Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-022549

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.